JY
PPBT

Jeff Yass’s Purple Biotech PPBT Stock Holding History

Jeff Yass’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.6K Sell
12,847
-40,556
-76% -$137K ﹤0.01% 13031
2026
Q1 		$216K Buy
53,403
+6,426
+14% +$34.7K ﹤0.01% 11539
2025
Q4 		$309K Buy
+46,977
New +$341K ﹤0.01% 9880
2022
Q3 		– Sell
-57
Closed -$26.6K – 13917
2022
Q2 		$27K Sell
57
-65
-53% -$38.9K ﹤0.01% 12268
2022
Q1 		$97K Sell
122
-50
-29% -$32.3K ﹤0.01% 11937
2021
Q4 		$134K Buy
+172
New +$147K ﹤0.01% 11917
2021
Q1 		– Sell
-103
Closed -$96.1K – 12707
2020
Q4 		$79K Buy
+103
New +$86.8K ﹤0.01% 10600
2020
Q3 		– Sell
-14
Closed -$30K – 11011
2020
Q2 		$30K Sell
14
-63
-82% -$61.9K ﹤0.01% 9864
2020
Q1 		$47K Buy
+77
New +$94.4K ﹤0.01% 9709
2019
Q2 		– Sell
-6
Closed -$14K – 10692
2019
Q1 		$14K Sell
6
-42
-88% -$101K ﹤0.01% 8631
2018
Q4 		$63K Buy
48
+32
+200% +$80.5K ﹤0.01% 8402
2018
Q3 		$57K Buy
+16
New +$63.3K ﹤0.01% 8804
2018
Q1 		– Sell
-8
Closed -$38K – 9993
2017
Q4 		$38K Buy
+8
New +$35.7K ﹤0.01% 8978

Other funds holding PPBT

SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
IA
IFG Advisory Atlanta, Georgia $2.85B AUM 26.07% 1-Year Est. Return

Jeff Yass's PPBT Position: Q2 2026 in Review

Jeff Yass reduced its Purple Biotech (PPBT) stake by 76% in Q2 2026, selling an estimated $137K and leaving 12,847 shares worth $21.6K. The position accounts for ﹤0.01% of the portfolio, ranked #13031.

Jeff Yass first reported a position in PPBT in Q4 2017 and has held it in 13 quarters since. The position peaked at $309K in Q4 2025. 13 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

  • Jeff Yass held 12,847 shares of Purple Biotech worth $21.6K as of Q2 2026.
  • Jeff Yass sold 40,556 Purple Biotech shares in Q2 2026, an estimated $137K.
  • Purple Biotech made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13031 holding.
  • Jeff Yass first reported a position in Purple Biotech in Q4 2017 and has held it in 13 quarters since.
  • Jeff Yass's Purple Biotech position peaked at $309K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.